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Abstract  
Quality of life (QoL) represents a dramatic issue in an aging population. Vitamin 
D has been consistently associated with several diseases. Thus, vitamin D may be 
considered a hallmark of health status. Our aim was to investigate whether 
vitamin D could be a determinant of self-perceived quality of life.  
The 36-Item Short Form Health Survey (SF-36) for quality of life, the Hamilton 
Anxiety Rating Scale (HAM-A), the Beck Depression Inventory II edition (BDI-
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II), in addition with multiple clinical risk factors for fractures and FRAX score, 
BMD at lumbar spine and femoral neck, were evaluated in a group of 177 
postmenopausal women referring to an outpatients clinic for the prevention of 
osteoporosis.  
Serum levels of vitamin D [25(OH)D], indicative of vitamin D status, were 
detected by high-performance liquid chromatography.  
Scores of each dimension of the SF-36 were significantly related with the 
measurements of anxiety and depression by HAM-A and BDI-II respectively. 
Moreover role emotional, vitality, general health and bodily pain were 
significantly associated with vitamin D status. However, at a stepwise multiple 
regression analysis the physical component summary, obtained from SF-36, was 
not independently predicted from vitamin D.  
In conclusion we found an association between vitamin D status and QoL, thus 
we suggest physicians to consider vitamin D levels as a marker of QoL.  
Further studies testing the impact of vitamin D administration in improving QoL 
over time are needed. 
 
Key words: Quality of life , Vitamin D, Anxiety, Depression, 
Osteoporosis, Vitality. 
  
Introduction  
The concept of quality of life is thought as a multidimensional construct which 
includes several different dimensions. It can be defined as the degree to which 
people perceive themselves physically, emotionally and socially. Quality of life is 
what precious makes life worth living (Rafiq et al., 2014).  
On the other hand, it is known that vitamin D has been traditionally considered as 
a main regulator of bone and mineral metabolism (Catalano et al., 2015, Holick, 
2007) and that its deficiency causes rickets in children and osteomalacia and 
osteoporosis in adults (Holick, 2007). 
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Several scientific evidences, from in vivo and in vitro studies, suggest that 
vitamin D represents a crucial determinant for the development of major clinical 
conditions and health-related events (Holick, 2004). A large number of 
extraskeletal disorders as immune, metabolic, cardiovascular, neurological and 
oncological, have been previously associated with vitamin D (Brighenti et al. 
2018, Wu et al., 2016; Smolders et al., 2011; Goodwill & Szoeke, 2017;  
Atteritano et al., 2016; Chu et al., 2017; Catalano et al. 2017; Fedotova et al., 
2017; Catalano et al., 2015b). Especially in the elderly, a poor vitamin D status 
has been accompanied by cognitive and mood disorders (Merendino et al., 2004; 
Nguyen, T.T.T. et al., 2017; Pu, D. et al., 2018), muscle weakness, poor physical 
performance, balance problems and falls (Gerdhem et al., 2005). Recently 
vitamin D has been also associated with psychological features as depressive and 
anxiety symptoms (Atteritano et al., 2013; de Koning et al. 2017; Martino et al., 
2018; Catalano et al., 2018). 
Consequently, vitamin D deficiency may not only influence the onset of chronic 
conditions, which are frequent causes of disability, but may also affect 
psychological and physical functional status.  
Since vitamin D is fundamentally involved in mental and physical function 
potentially influencing quality of life, the aim of this study was to investigate the 
associations between the perceived quality of life and the vitamin D status in 
outpatients postmenopausal women evaluated for osteoporosis. 
   
Methods  
The recruitment of postmenopausal women occurred at the Outpatients Clinic for 
the Prevention and Treatment of Osteoporosis at the Department of Clinical and 
Experimental Medicine, University Hospital of Messina. Women were excluded 
from the study if affected by a known psychiatric condition, including cognitive 
decline or addiction, by chronic diseases as from moderate to severe kidney or 
liver or respiratory failure, hearth failure with NYHA (New York Heart 
Association) class ≥2, history of cancer, malabsorption, endocrine disorders and 
if under treatment with bone or brain active agents (Catalano et al., 2013). 
Assumption of vitamin D and calcium supplements was not an exclusion criteria 
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if in accordance with the dietary reference intakes from the Institute of Medicine 
(Ross et al. 2015). 
The Italian version of the Short Form-36 (SF-36) questionnaire was used to 
measure the perception of the patient’s health. SF- 36 consists of 36 items 
organized in eight dimensions known as physical functioning, social functioning, 
role limitations because of physical problems, role limitations because of 
emotional problems, mental health, vitality, pain, and general health perception. 
For each dimension administered, a score ranged from 0 to 100 points was 
obtained, with higher scores indicating a better perception of quality of life, with 
less roles limitations too (Ware et al.,1992) 
The Hamilton Anxiety Rating Scale (HAM-A) was performed to evaluate the 
entity of anxiety symptoms; it consists of 14 symptom-defined elements, 
including psychological and somatic symptoms. Tension (e.g. fatigability, 
restlessness); fears (e.g. dark/strangers/crowds); insomnia 
(initial/intermediate/late); intellectual (e.g. poor memory); depressed mood; 
somatic symptoms (e.g. aches and pain); sensory (e.g. tinnitus, blurred vision); 
cardiovascular (including tachycardia and palpitations); respiratory (chest 
tightness, choking); gastrointestinal (e.g. irritable bowel syndrome-type 
symptoms); genitourinary (e.g. urinary frequency, loss of libido); autonomic (e.g. 
dry mouth, tension headache) and observed behaviour at interview (as restless or 
fidgety). Each item results in a numeric score from 0 to 4 directly proportional to 
the entity of perceived symptom (Hamilton et al. 1959). The Beck Depression 
Inventory-second edition (BDI-II), consisting of 21 items, each scored from 0 to 
4, was implemented to detect depressive symptoms (Beck et al. 1996).  
A computer-based algorithm (http://www.shef.ac.uk/FRAX) was applied to 
evaluate the 10-year probability of a major fracture and femoral fracture on the 
basis of clinical risk factors as prior fragility fracture, parental history of hip 
fracture, current tobacco smoking, ever use of long-term oral glucocorticoids, 
rheumatoid arthritis and secondary causes of osteoporosis.  
Bone mineral density (BMD) was detected through dual-energy X-ray 
absorptiometry (DXA) densitometer at the femoral neck and lumbar spine (L1-
L4).  
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A blood sample was collected for each woman to evaluate vitamin D status 
measuring 25(OH)D plasmatic levels through high-performance liquid 
chromatography (Ju, S.Y. et al., 2013; de Koning, E.J. et al., 2017). Our study 
was carried out in accordance with the 1964 Declaration of Helsinki and its later 
amendments, and written informed consent was obtained from all the participants. 
Statistical analyses were achieved by MedCalc software (version 10.2.0.0; 
Mariakerke, 173 Belgium). Differences were evaluated using the Student’s t-test 
for unpaired observations or Mann-Whitney test as appropriate. The degree of 
association between two selected variables was calculated by Pearson correlation 
coefficient. A multiple regression analysis was conducted in order to investigate 
the relationship between a dependent variable and one or more predictive 
variables. Values of P <0.05 were considered to indicate statistical significance.  
 
Results 
We recruited a total of 177 postmenopausal women, aged 67 ± 9.57 yr., whose 
main clinical characteristics are shown in Table 1.  
Table 1 - Main clinical features of postmenopausal women.  
                                                       Results (n=177)  
 
Age (yr)                                    67 ± 9.57 
Age at menopause (yr)            47.5 ± 5.94 
Time since menopause (yr)              20.63 ± 9.08 
Weight (kg)                                   62.78 ± 13.18 
Height (cm)                                   158.29 ± 5.94 
BMI (Kg/m2)                                   24.97 ± 5.11 
Current smoking [ n(%)]                  19 (10) 
Lumbar spine T-Score [SD]            -2.29 ± 1.35 
Femoral neck T-Score [SD]             -1.98 ± 0.81 
10-year probability                           20.1 ± 9.7 
of a major fracture (%)  
25(OH)D (ng/ml)                       39.11 ± 14.69 
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Data are expressed as mean ± SD 
 
On the overage, patients were considered ―osteopenic‖ in accordance with the 
WHO criteria (World Health Organization 1994) and showed sufficient plasmatic 
concentration of vitamin D. They were slight overweight and a smoking habit was 
encountered in 10% of them. 
Table 2 shows the results for the eight dimensions of the SF-36 questionnaire and 
the mean values of mental and physical health. HAM-A mean score was 27.72 ± 
6.84 and BDI-II mean score was 7.26 ± 3.34.  
 
Table 2 - Measurement of quality of life through SF-36 questionnaire. 
 
 
 
 
 
 
 
 
 
 
 
Data are expressed as mean ± SD 
It was interesting the finding that the scores of each dimension of the SF-36 were 
significantly related with the measurement of anxiety and depression by HAM-A 
and BDI-II respectively. Moreover the dimensions role emotional, vitality, 
general health and bodily pain were significantly associated with vitamin D 
status (Table 3). 
 
 Results 
(n=177) 
Mental health 34.12 ± 19.97 
Role emotional 20.17 ± 29.77 
Social functioning 43.34 ± 20.63 
Vitality 35.07  ± 15.91 
General health 38.04  ± 18.69 
Bodily pain 37.45  ± 23.93 
Role physical 19.53  ± 30.21 
Physical functioning  54.45  ± 26.32 
Physical component summary 36.04 ± 8.80 
Mental component summary 30.187 ± 8.49 
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Table 3 - Correlation coefficients (r) between studied variables 
 
Statistically significant values of ―r‖ (p<0.05) are shown in bold. 
At a stepwise multiple regression analysis it turned out that age, BMI, HAM-A 
score, BDI-II score and femoral neck BMD were independently associated with 
the physical component summary (PCS) after correcting for mental component 
summary (MCI), age at menopause, lumbar spine BMD and vitamin D status 
(p<0.05). 
Discussion 
The findings from this cross-sectional study suggest that quality of life is 
associated with vitamin D status in postmenopausal women referred for 
osteoporosis. However this association was lost after adjusting for confounders. 
Vitamin D receptor (VDR) is widespread to make plausible pleiotropic action of 
vitamin D on a large spectrum of systems, apparatuses and tissues (Timpini et al. 
 Age Age at menopause BMI HAM-A score BDI-II score 25(OH)D 
Mental health 0.34 -0.14 0.05 -0.47 -0.52 0.05 
Role emotional 0.29 -0.06 -0.06 -0.51 -0.32 0.20 
Social functioning 0.33 -0.07 0.02 -0.44 -0.46 0.11 
Vitality 0.28 -0.24 -0.04 -0.47 -0.47 0.15 
General health 0.29 0.06 0.03 -0.52 -0.53 0.14 
Bodily pain 0.44 -0.15 -0.11 -0.45 -0.43 0.16 
Role physical 0.15 -0.09 -0.07 -0.43 -0.30 0.02 
Physical functioning  0.48 -0.06 -0.04 -0.54 -0.39 0.06 
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2011; Windelinckx et al., 2007). Thus, vitamin D has growingly been involved 
as a primary determinant of biological modifications and specific clinical 
conditions. As known, the role of vitamin D extends beyond calcium 
homeostasis and includes modulation of skeletal and cardiac muscle function, 
immune cell function, and anticancer activity (Holick, 2004, Catalano et al 
2013). Vitamin D is mainly involved also in the developing brain and in adult 
brain function (Hayes, 2010). VDRs  are expressed  in  areas  of  the  brain  
important  to  behavioral  regulation, including  the  cortex,  cerebellum,  and  
limbic  system.  In  animal models,  mice  with  genetically  impaired  VDRs  
had  abnormal  brain shapes,  decreased  levels  of  neural  growth  factors,  and  
exhibited behavioral  aberrations  including  high  anxiety,  poor  grooming,  and 
poor  social  interaction  (Kalueff et al., 2007). 
VDR gene polymorphisms able to determine different phenotypes and biological 
responses to vitamin D have been described, not only able to affect bone mineral 
density, but also body composition, muscle strength and other clinical outcomes 
suggesting a role for vitamin D in determining age-related physical decline, and 
disabling process (Cesari et al. 2011). 
Low vitamin D levels is frequently encountered in the elderly, since the aging 
process itself predisposes to a progressive decline in the cutaneous capacity to 
synthesize vitamin D from ultraviolet B radiations and an increased resistance of 
target organs to the vitamin D action due to reduced concentrations of VDRs or 
post-receptorial modifications (Hayes, 2010; Armstrong, D.J., 2007). 
Whether vitamin D may be an elisir able to improve quality of life remain an 
unsolved question, since available evidence are inconsistent (Callegari et al., 
2017). Data from a  cross-sectional  analysis  of  the  Iowa  Women’s  Health  
Study showed that women who consumed  at  least  400  IU/day  of vitamin D 
showed slightly  higher  mental  health related  QoL  scores  compared  to  
women  who  consumed  less  than 400 UI/day (Motsinger et al., 2012; Michelle 
et al., 2015; Lerchbaum, 2014). However in a 2-year, double-blind, placebo-
controlled vitamin D and open exercise intervention trial, neither vitamin D (800 
UI/day) nor exercise contributes to better QoL, or mental wellbeing in 
community-dwelling healthy older women with sufficient vitamin D levels (Patil 
et al., 2016).  
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Although the key role of vitamin D in human biology and pathophysiology, 
whether quality of life may depend directly from vitamin D status was not 
supported from our study and we hypotized that a poorer quality of life observed 
in subjects with lower vitamin D levels may merely be the indirect manifestation 
of a poorer health status. 
We must recognize some limitations of our study. First, the exclusion of patients 
with more severe diseases, decided to exclude a deterioration in the quality of 
life due to serious medical or psychological-clinical pathology. Second, the 
cross-sectional design not able to investigate the causality of association. Third 
the absence of corrections for common non complicated diseases. The strength 
of our research consists in a large sample size involving only postmenopausal 
women, so that gender differences are excluded.  
Since the high prevalence of hypovitaminosis D, searching for at risk patients for 
hypovitaminosis D may also offer an opportunity to find people with a poor 
quality of life. Thus QoL could be improved with several strategies, 
proportionally to the psychological and physical needs highlighted (Langher et 
al., 2017). 
In conclusion we found an association between vitamin D status and QoL, thus 
we suggest physicians to consider vitamin D levels as a marker of QoL.  
Further prospective research studies calibrated with adequate doses of vitamin D 
may be useful to establish the possible impact of vitamin D administration in 
improving QoL over time (Merlo, E.M., 2016). 
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